Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Other Non-Current Assets (2016 - 2022)

Catalyst Pharmaceuticals filings provide 13 years of Other Non-Current Assets readings, the most recent being $9000.0 for Q4 2022.

  • On a quarterly basis, Other Non-Current Assets changed 0.0% to $9000.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $9000.0, a 0.0% change, with the full-year FY2022 number at $9000.0, changed 0.0% from a year prior.
  • Other Non-Current Assets hit $9000.0 in Q4 2022 for Catalyst Pharmaceuticals, roughly flat from $9000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $9000.0 in Q4 2020 to a low of $8888.0 in Q1 2018.
  • Median Other Non-Current Assets over the past 5 years was $8888.0 (2018), compared with a mean of $8938.4.
  • Biggest five-year swings in Other Non-Current Assets: changed 0.0% in 2018 and later increased 1.26% in 2020.
  • Catalyst Pharmaceuticals' Other Non-Current Assets stood at $8888.0 in 2018, then changed by 0.0% to $8888.0 in 2019, then increased by 1.26% to $9000.0 in 2020, then changed by 0.0% to $9000.0 in 2021, then changed by 0.0% to $9000.0 in 2022.
  • The last three reported values for Other Non-Current Assets were $9000.0 (Q4 2022), $9000.0 (Q3 2022), and $9000.0 (Q2 2022) per Business Quant data.